Morbidity After Surgical Treatment of Perforated Ulcer

• Sponsor: University of Monastir (Other)
• Overall Status: Completed
• CT.gov ID: NCT05489497
• Collaborator: (none)
• Enrollment: 116
• Actual Duration (Months): 137

Study Details

Study Description

Brief Summary

The main objective of our study is to identify the risk factors for postoperative morbidity after surgical treatment of Perforated peptic ulcer

Condition or Disease	Intervention/Treatment	Phase
Peptic Ulcer Perforation	Procedure: Primary closure with or without omental grafting

Detailed Description

the investigators conducted a retrospective study of 116 patients, operated on for a perforated peptic ulcer, carried out in the General Surgery Department of Taher Sfar University Hospital in Mahdia over a period of 11 years 6 months.

Study Design

• Study Type: Observational
• Anticipated Enrollment: 116 participants
• Observational Model: Case-Control
• Time Perspective: Retrospective
• Official Title: Postoperative Morbidity Risk Factors After Surgical Treatment of Perforated Peptic Ulcer: a Retrospective Study of 116 Patients
• Actual Study Start Date: Jan 1, 2010
• Actual Primary Completion Date: May 1, 2021
• Actual Study Completion Date: Jun 1, 2021

Outcome Measures

Primary Outcome Measures

1. postoperative medical or surgical complication [baseline]

   the investigators determined the number of Participants With postoperative medical or surgical complication after surgical treatement of perforated ulcer

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• patients who underwent surgery for a perforated peptic ulcer in the General Surgery Department of Taher Sfar University Hospital in Mahdia, between January 1, 2010, and June 1, 2021, were included in this study.

Exclusion Criteria:

• patients who have medical treatment

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

• University of Monastir

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Ghannouchi Mossaab, doctor, University of Monastir
• ClinicalTrials.gov Identifier: NCT05489497
• Other Study ID Numbers: perforated ulcer
• First Posted: Aug 5, 2022
• Last Update Posted: Aug 5, 2022
• Last Verified: Aug 1, 2022

• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Keywords provided by Ghannouchi Mossaab, doctor, University of Monastir: Postoperative complication; Risk factor
• Additional relevant MeSH terms: Peptic Ulcer; Peptic Ulcer Perforation; Ulcer

Study Results

No Results Posted as of Aug 5, 2022